AmnioLife Corporation Closes Series A Round With Additional Infusion From Fountainhead Investment Partners GAINESVILLE, Fla., Jan. 06, 2016 (GLOBE NEWSWIRE) -- AmnioLife Corporation, a human cells, tissues, and cellular and tissue-based products developer, and San Antonio-based Fountainhead Investment...